As of June 10, 2025, Prestige Consumer Healthcare Inc (PBH) reports a Net Margin of 18.86%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Prestige Consumer Healthcare Inc's Net Margin
Over recent years, Prestige Consumer Healthcare Inc's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2025-03-31 | 18.86% |
| 2024-03-31 | 18.60% |
| 2023-03-31 | -7.30% |
| 2022-03-31 | 18.90% |
| 2021-03-31 | 17.46% |
This slight upward trend highlights how Prestige Consumer Healthcare Inc manages its overall profitability and cost control over time.
Comparing Prestige Consumer Healthcare Inc's Net Margin to Peers
To better understand Prestige Consumer Healthcare Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Prestige Consumer Healthcare Inc (PBH) | 18.86% |
| Royalty Pharma PLC (RPRX) | 37.95% |
| Zoetis Inc (ZTS) | 26.86% |
| Merck & Co Inc (MRK) | 26.68% |
| Eli Lilly and Co (LLY) | 23.51% |
| Amphastar Pharmaceuticals Inc (AMPH) | 21.79% |
Compared to its competitors, Prestige Consumer Healthcare Inc's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.